Reliq Health Technologies Past Earnings Performance
Past criteria checks 0/6
Reliq Health Technologies has been growing earnings at an average annual rate of 95.1%, while the Healthcare Services industry saw earnings growing at 2.2% annually. Revenues have been growing at an average rate of 119.4% per year.
Key information
95.1%
Earnings growth rate
95.2%
EPS growth rate
Healthcare Services Industry Growth | 7.9% |
Revenue growth rate | 119.4% |
Return on equity | -3.4% |
Net Margin | -3.1% |
Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Reliq Health Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 23 | 15 | 0 | 7 | 3 |
31 Dec 22 | 12 | -2 | 6 | 4 |
30 Sep 22 | 10 | -4 | 8 | 3 |
30 Jun 22 | 9 | -8 | 11 | 2 |
31 Mar 22 | 7 | -9 | 12 | 2 |
31 Dec 21 | 5 | -11 | 13 | 1 |
30 Sep 21 | 3 | -13 | 14 | 1 |
30 Jun 21 | 1 | -12 | 11 | 2 |
31 Mar 21 | 1 | -11 | 10 | 1 |
31 Dec 20 | 1 | -11 | 10 | 1 |
30 Sep 20 | 1 | -11 | 9 | 2 |
30 Jun 20 | 1 | -11 | 9 | 2 |
31 Mar 20 | 1 | -14 | 10 | 3 |
31 Dec 19 | 1 | -14 | 10 | 4 |
30 Sep 19 | 0 | -12 | 8 | 4 |
30 Jun 19 | 0 | -13 | 8 | 5 |
31 Mar 19 | 0 | -17 | 12 | 4 |
31 Dec 18 | 1 | -18 | 14 | 4 |
30 Sep 18 | 2 | -16 | 14 | 3 |
30 Jun 18 | 2 | -14 | 13 | 1 |
31 Mar 18 | 2 | -7 | 7 | 1 |
31 Dec 17 | 1 | -3 | 3 | 1 |
30 Sep 17 | 0 | -3 | 3 | 1 |
30 Jun 17 | 0 | -2 | 2 | 1 |
31 Mar 17 | 0 | -3 | 2 | 1 |
31 Dec 16 | 0 | -3 | 2 | 0 |
30 Sep 16 | 1 | -3 | 2 | 0 |
30 Jun 16 | 1 | -3 | 2 | 0 |
31 Mar 16 | 1 | -3 | 3 | 0 |
31 Dec 15 | 0 | -5 | 3 | 0 |
30 Sep 15 | 0 | -5 | 2 | 0 |
30 Jun 15 | 0 | -5 | 2 | 0 |
31 Mar 15 | 0 | -4 | 1 | 0 |
30 Sep 14 | 0 | -1 | 1 | 0 |
30 Jun 14 | 0 | -1 | 0 | 0 |
30 Jun 13 | 0 | -1 | 0 | 1 |
Quality Earnings: MHN2 is currently unprofitable.
Growing Profit Margin: MHN2 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if MHN2's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare MHN2's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MHN2 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-12.8%).
Return on Equity
High ROE: MHN2 has a negative Return on Equity (-3.41%), as it is currently unprofitable.